Explaining the FDA 1271 Regs Using Common Orthobiologics

Dr Centeno discusses the FDAs 1271 regulations by classifying common orthbiologics into either a medical procedure, 361 tissue, or 351 drug.

Regenexx® Webinar

Join Chris Centeno, M.D., founder of Regenexx, to learn about how Regenexx procedures can treat your orthopedic injury.

Find a Regenexx Provider

Regenexx is a world-wide network of specially trained physicians providing the world's most advanced, research-driven, regenerative-medicine treatments in North America, Europe, the Middle East, Asia and Australia.

Copyright © Regenexx 2021. All rights reserved.

CONTACT INFORMATION

Address

9035 Wadsworth Pkwy #1000
Westminster, CO 80021

Phone

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email
TO TOP